Antibodies News and Research

RSS

New technology harnesses a natural feature of therapeutic antibodies to attack blood cancer cells

Researchers at the University of Southampton and biopharma company UCB have found a way to enhance the natural ability of therapeutic antibodies to attack blood cancer cells using part of the human immune system known as the complement cascade, opening the way for a potential new class of treatments.

8 Sep 2021

Study details replication and immune evasion of Delta SARS-CoV-2 variant

According to scientists, the Delta variant of SARS-CoV-2 has likely spread through its capability to avoid neutralizing antibodies and its heightened infectivity.

8 Sep 2021

Researchers develop a new system for rapid, sensitive measurement of antibodies against SARS-CoV-2

A research team at the RIKEN Center for Emergent Matter Science in Japan has developed a diagnostic system that can rapidly and sensitively measure the amount of antibodies in the blood that can protect us from SARS-CoV-2, the virus that causes COVID-19.

6 Sep 2021

New drug delivery strategy could make it easier for patients to take their medications

In recent years, scientists have developed monoclonal antibodies -; proteins that mimic the body's own immune defenses -; that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn's disease.

31 Aug 2021

Small synthetic molecules could one day cure or prevent COVID-19, herpes

In addition to antibodies and white blood cells, the immune system deploys peptides to fight viruses and other pathogens.

24 Aug 2021

Scientists isolate monoclonal antibodies against alphaviruses

A research group has isolated monoclonal antibodies that, in laboratory and animal studies, prohibited infection by alphaviruses.

From Vanderbilt University 24 Aug 2021

Researchers identify potent antibody that protects against a wide range of viral variants

The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019.

23 Aug 2021

COVID-19 vaccine-induced antibody protects against delta variant

Despite causing a surge in infections this summer that has resulted in thousands of hospitalizations and deaths, the delta variant of the virus that causes COVID-19 is not particularly good at evading the antibodies generated by vaccination, according to a study by researchers at Washington University School of Medicine in St. Louis.

18 Aug 2021

Researchers modify CRISPR to enable antibody-based medical diagnostics

Researchers adapted CRISPR to analyze antibodies in patient blood samples to pave the way for a new class of medical diagnostics.

From Harvard Medical School 16 Aug 2021

Study assesses the effectiveness of T-cell immune response to different SARS-CoV-2 variants

New mutations of the SARS-CoV-2 virus have been emerging continuously, enabling a more potent spread of the virus and allowing it to evade antibodies.

16 Aug 2021

New molecule can effectively deplete cancer-protecting cells inside tumors

A new study has discovered a two-arm molecule that can effectively deplete cancer-protecting cells within tumors.

16 Aug 2021

New study could help design more effective vaccines against various COVID-19 variants

Scientists have discovered that individuals recovering from COVID-19 produce identical clones, or groups, of antibody-producing white blood cells.

From Vanderbilt University 12 Aug 2021

T cell-depleted macaques can mount potent memory responses against SARS-CoV-2

New research conducted in monkeys reveals that T cells are not critical for the recovery of primates from acute COVID-19 infections.

28 Jul 2021

New formulation to administer antibodies for choroidal neovascularization therapy

Scientists have created a new formulation based on regulatory T-cell exosomes (rEXS) to administer vascular endothelial growth factor (VEGF) antibodies.

28 Jul 2021

Researchers develop repository showcasing antibody activity on spike protein variants

Scientists have created an “atlas” that charts how 152 different antibodies attack a major piece of the SARS-CoV-2 machinery, the spike protein.

27 Jul 2021

Study employs llama nanobodies to hunt human cytomegalovirus

Researchers created a “nanobody”, a small fragment of a llama antibody, that can evade human cytomegalovirus as it hides away from the immune system.

26 Jul 2021

Study reveals SARS-CoV-2 variant is less sensitive to inhibition by antibodies

SARS-CoV-2 is still a major threat to humankind. The constant emergence of variants makes the threat made by the virus difficult to estimate. The SARS-CoV-2 variant B.1.617 spread in India and gave rise to the Delta variant, B.1.617.2, which is now dominant in numerous countries.

23 Jul 2021

Antibodies News and Research

New technology harnesses a natural feature of therapeutic antibodies to attack blood cancer cells

Study details replication and immune evasion of Delta SARS-CoV-2 variant

Researchers develop a new system for rapid, sensitive measurement of antibodies against SARS-CoV-2

New drug delivery strategy could make it easier for patients to take their medications

Small synthetic molecules could one day cure or prevent COVID-19, herpes

Scientists isolate monoclonal antibodies against alphaviruses

Researchers identify potent antibody that protects against a wide range of viral variants

COVID-19 vaccine-induced antibody protects against delta variant

Researchers modify CRISPR to enable antibody-based medical diagnostics

Study assesses the effectiveness of T-cell immune response to different SARS-CoV-2 variants

New molecule can effectively deplete cancer-protecting cells inside tumors

New study could help design more effective vaccines against various COVID-19 variants

T cell-depleted macaques can mount potent memory responses against SARS-CoV-2

New formulation to administer antibodies for choroidal neovascularization therapy

Researchers develop repository showcasing antibody activity on spike protein variants

Study employs llama nanobodies to hunt human cytomegalovirus

Study reveals SARS-CoV-2 variant is less sensitive to inhibition by antibodies

SARS-CoV-2 variant B.1.617 can infect lung and intestinal cells more efficiently than the original virus

L452R mutation of SARS-CoV-2 spike protein is involved in cellular immunity evasion

Study confirms long-term immune system responses of adenovirus vaccines for COVID-19

Antibodies eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics